3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Prostatic Neoplasms
4
Oropharyngeal Neoplasms
3
Laryngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Mouth Neoplasms
2
Mesothelioma
2
Hypopharyngeal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Astrocytoma
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Sarcoma
1
Salivary Gland Neoplasms
1
PSA Level Greater Than Two
1
Oligodendroglioma
1
Nasopharyngeal Carcinoma
1
Mesothelioma, Malignant
1
Lymphoma, Follicular
1
Lymphoid Interstitial Pneumonia
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Carcinoma, Squamous Cell
1
Interventions
Rituximab
12
Cyclophosphamide
12
Biopsy
12
Specimen Handling
11
Magnetic Resonance Spectroscopy
10
obinutuzumab
7
fludarabine
7
Lenalidomide
7
Prednisone
6
pembrolizumab
5
Nuclear Medicine Department, Hospital
5
fludarabine phosphate
4
X-Rays
4
Tacrolimus
4
Mycophenolic Acid
4
Doxorubicin
4
Busulfan
4
venetoclax
3
ibrutinib
3
glofitamab
3
acalabrutinib
3
Whole-Body Irradiation
3
Vincristine
3
GSK2636771
3
Etoposide
3
Bendamustine Hydrochloride
3
zanubrutinib
2
trametinib
2
tocilizumab
2
palbociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.